In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor
- PMID: 7690421
- PMCID: PMC238044
- DOI: 10.1128/JVI.67.10.6224-6233.1993
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor
Abstract
Recent genetic experiments have suggested that tat transactivation of the human immunodeficiency virus type 1 (HIV-1) long terminal repeat requires functional upstream enhancer sequences--Sp1 sites, in particular. In these experiments, HeLa cell nuclear extracts were passed over affinity matrices containing chemically synthesized or bacterially expressed HIV-1 Tat. Assay of material that bound to and eluted from the Tat matrices revealed the presence of the Sp1 transcription factor. Other transcription factors (Oct and NF-kappa B) also bound to Tat matrices but with less efficiency--in parallel with the lower capacities of these binding motifs to confer Tat responsiveness on a basal HIV-1 promoter compared with Sp1 sites. Passage of nuclear extracts over matrices containing other neutral proteins, including bovine serum albumin, ovalbumin, and lysozyme, revealed no or reduced binding. Cross-linking experiments indicated that the purified Sp1 and Tat proteins can form multimeric complexes in the absence of other proteins. The region of Tat responsible for Sp1 binding was localized to a region encompassing residues 30 to 62. Immunoprecipitation experiments with HIV-1-infected T lymphocytes indicated coimmunoprecipitation of Tat and Sp1. These experiments extend previous genetic experiments and suggest a direct interaction between Tat and Sp1 during transactivation.
Similar articles
-
Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.Virology. 1997 Aug 18;235(1):48-64. doi: 10.1006/viro.1997.8672. Virology. 1997. PMID: 9300036
-
Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.J Virol. 1994 May;68(5):3298-307. doi: 10.1128/JVI.68.5.3298-3307.1994. J Virol. 1994. PMID: 8151790 Free PMC article.
-
Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes.J Gen Virol. 2006 Jun;87(Pt 6):1613-1623. doi: 10.1099/vir.0.81691-0. J Gen Virol. 2006. PMID: 16690926
-
Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.J Virol. 1993 May;67(5):2853-61. doi: 10.1128/JVI.67.5.2853-2861.1993. J Virol. 1993. PMID: 8386279 Free PMC article.
-
Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat.J Virol. 1995 Oct;69(10):6572-6. doi: 10.1128/JVI.69.10.6572-6576.1995. J Virol. 1995. PMID: 7666561 Free PMC article.
Cited by
-
Tat gets the "green" light on transcription initiation.Retrovirology. 2005 Nov 9;2:69. doi: 10.1186/1742-4690-2-69. Retrovirology. 2005. PMID: 16280076 Free PMC article. Review.
-
Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells.J Virol. 2006 Sep;80(18):9288-99. doi: 10.1128/JVI.02138-05. J Virol. 2006. PMID: 16940540 Free PMC article.
-
Improving HIV proteome annotation: new features of BioAfrica HIV Proteomics Resource.Database (Oxford). 2016 Apr 17;2016:baw045. doi: 10.1093/database/baw045. Print 2016. Database (Oxford). 2016. PMID: 27087306 Free PMC article.
-
Preventive effect of ascorbic acid against biological function of human immunodeficiency virus trans-activator of transcription.J Intercult Ethnopharmacol. 2016 Apr 6;5(2):205-9. doi: 10.5455/jice.20160316010322. eCollection 2016 Mar-Apr. J Intercult Ethnopharmacol. 2016. PMID: 27104044 Free PMC article. No abstract available.
-
The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.J Virol. 2000 Feb;74(4):1632-40. doi: 10.1128/jvi.74.4.1632-1640.2000. J Virol. 2000. PMID: 10644332 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources